U.S. Specialized REITs Stock News

MannKind Corporation recently reported its second-quarter 2026 results, with revenue rising to US$109.37 million from US$76.53 million a year earlier while moving from a small net profit to a net loss of US$19.03 million. A few days earlier, MannKind released positive Phase 1b data for its inhaled nintedanib in idiopathic pulmonary fibrosis, underscoring the potential of its Technosphere platform to extend into high-need lung indications beyond its current commercial products. We’ll now...

Spotify Technology has fallen sharply over the past year but still screens as attractively priced on Simply Wall St's intrinsic value checks, with the Discounted Cash Flow (DCF) estimate pointing to a meaningful gap to the current share price even as market multiples suggest the stock is closer to fair. Spotify Technology has returned about 252% over the past 3 years, which means investors are now weighing a strong multi year run against whether the current price still offers enough...

Structure Therapeutics recently advanced its obesity portfolio by dosing the first patients in its Phase 3 ACCOMPLISH trial of oral aleniglipron and appointing veteran commercial leader John Berrios as Chief Commercial Officer. The combination of late-stage trial progress and leadership drawn from major obesity and diabetes franchises highlights Structure’s focus on preparing aleniglipron for potential large-scale commercialization. Next, we’ll examine how the Phase 3 launch of aleniglipron...

UroGen Pharma stock has delivered very strong share price returns over the past five years, yet its current valuation checks and market multiples now suggest the shares are closer to fairly priced than a clear bargain. UroGen Pharma has returned about 210% over the last 5 years, which puts recent gains front and center when judging whether the current price already reflects much of that success. Expectations around UroGen Pharma’s ability to grow revenue and eventually convert its pipeline...

Berkshire Hathaway’s renewed buying spree under Greg Abel, including a US$10b move into Alphabet and billions more in equities, has turned a quiet market narrative into something far more exciting for stock pickers. When a giant like Berkshire starts writing big checks again, many investors worry about missing the next wave of opportunity. This article looks at three stocks tied to that shift and how this renewed confidence could matter for your portfolio decisions. Berkshire Hathaway...

Global Partners (GLP) is back on investor radar after reporting second quarter 2026 results, with higher sales, net income, earnings per unit, and a recent cash distribution announcement drawing fresh attention to the stock. See our latest analysis for Global Partners. The latest earnings release and July cash distribution decision have arrived alongside a solid share price trend for Global Partners, with the stock up 18.74% year to date on a share price return basis and a 5.09% total...

Meta Platforms stock has pulled back this year even though the valuation work still leans positive, with the Discounted Cash Flow (DCF) intrinsic value estimate and earnings based multiples both pointing to an undervalued share price relative to those fundamentals. Meta Platforms has returned about 98% over the past 3 years, which means many investors are now asking whether the recent share price leaves enough room for further value to be realised. Heavy investment in AI infrastructure and...

In late July 2026, InterDigital, Inc. reported that second-quarter sales fell to US$260.17 million and net income to US$116.37 million, yet also updated investors on ongoing share repurchases. Despite weaker quarterly results, the company raised its full-year 2026 revenue and earnings guidance, signaling management confidence in a stronger second half. Next, we’ll examine how InterDigital’s upgraded full-year 2026 guidance reshapes the existing investment narrative around its earnings...

Cavco Industries (CVCO) is back in focus after reporting record quarterly revenue alongside a sharply higher order backlog, while margin pressure and the new ROAD to Housing Act give investors fresh factors to weigh. See our latest analysis for Cavco Industries. The share price reaction has been steady rather than explosive. Cavco Industries has a 90 day share price return of 22.23% and a 1 year total shareholder return of 30.39%, while the 3 year total shareholder return of 101.83% points to...

In the second quarter of 2026, Scorpio Tankers Inc. reported net income of US$387.54 million and sharply higher earnings per share versus a year earlier, alongside strong first-half results. The company also continued returning cash to shareholders through a US$0.45 quarterly dividend and extensive share repurchases that have retired more than a quarter of its shares since 2023. Next, we’ll examine how this surge in profitability and recent share repurchases interact with Scorpio Tankers’...

UL Solutions Inc. has reported past second-quarter 2026 results showing sales of US$816 million versus US$776 million a year earlier, with net income rising to US$246 million from US$91 million and diluted EPS from continuing operations increasing to US$1.21 from US$0.45. An interesting angle for investors is the sharp expansion in profitability, as net income grew far faster than sales, indicating stronger operating efficiency and margin performance over the period. Next, we will examine...

AeroVironment stock has delivered a strong 3 year run, yet its current valuation signals are split, with a Discounted Cash Flow (DCF) intrinsic value estimate indicating about 10.3% upside while market based multiples point to a richer pricing and an overall low value score. AeroVironment has returned 95.2% over the past 3 years, which puts recent share price weakness into the context of a much stronger longer term move. The recent collaboration with Applied Intuition on uncrewed teaming...

Hinge Health (HNGE) drew fresh investor attention on 4 August 2026 after reporting second quarter earnings, raising full year guidance, updating its share buyback activity, and outlining expansion plans in digital gastrointestinal care. See our latest analysis for Hinge Health. The latest results and acquisition news came on top of strong recent momentum in Hinge Health's stock, with a 1 day share price return of 11.55%, a 7 day share price return of 19.57% and a 90 day share price return of...

Why Enpro stock is in focus after raised 2026 guidance Enpro (NPO) is back on investor radars after the company lifted its 2026 revenue growth outlook to a range of 14% to 16%, alongside reporting second quarter 2026 results and affirming its quarterly dividend. See our latest analysis for Enpro. Enpro's raised 2026 guidance and solid second quarter results have come after a strong run, with the share price up 51.9% year to date and supported by a 56.38% 1 year total shareholder return. Multi...

Glaukos (GKOS) is back in focus after reporting record second quarter net sales, supported by iDose TR and the Epioxa launch, and raising its full year 2026 net sales guidance. See our latest analysis for Glaukos. The earnings beat and higher 2026 sales guidance have fed into strong momentum for Glaukos, with a 30 day share price return of 17.69% and year to date share price return of 62.59%. Over a longer horizon, the 1 year total shareholder return of 112.66% suggests recent enthusiasm has...

Interface guidance and earnings put recent stock gains in focus Interface (TILE) has just issued new third quarter 2026 sales guidance alongside its second quarter earnings report, giving you fresh numbers to weigh against the stock’s strong recent share price performance. The company now projects third quarter net sales between $370 million and $380 million and has also raised its full year 2026 net sales outlook to a range of $1.455b to $1.485b, slightly above its previous forecast. See our...

Earnings and Buyback Activity Set the Context for Asbury Automotive Group Stock Asbury Automotive Group (ABG) recently reported second quarter 2026 results, with revenue of US$4,384.6 million and net income of US$114.6 million, alongside ongoing share repurchases under its multi year buyback program. From April to June 2026, the company repurchased 668,000 shares for US$131 million, completing 2,855,333 shares bought back in total. This retirement of stock influences per share metrics and can...

What Omnicom Group’s Latest Earnings Mean For Investors Omnicom Group (OMC) just released second quarter 2026 results that showed higher sales, net income, and earnings per share compared with a year earlier. These figures, combined with an active buyback program, have drawn fresh attention to the stock. See our latest analysis for Omnicom Group. Omnicom Group’s recent earnings update and completed buyback come alongside a 30 day share price return of 8.45% and a 90 day share price return of...

After high profile hacks at AI platforms such as Hugging Face and Anthropic’s Claude, cybersecurity stocks are in the spotlight for all the right and wrong reasons. Risks feel sharper, and that can quickly reshape where capital flows next. For investors, that mix of fear and urgency can create openings. This article looks at 3 cybersecurity stocks exposed to the latest AI security shock and why they may deserve a closer look. The stocks highlighted below are just a starting sample, and the...

Rayonier earnings and buyback update Rayonier (RYN) reported second quarter 2026 results this week, with earnings per share from continuing operations unchanged year over year, while total net income was significantly lower and the share repurchase program advanced. See our latest analysis for Rayonier. Despite stable earnings per share from continuing operations, Rayonier’s recent second quarter report and ongoing buybacks have not translated into strong overall returns. The share price at...

In recent weeks, Dr. Reju-All announced the nationwide rollout of five clinically focused skincare products into select Ulta Beauty stores and online, while Pacsun and Ulta Beauty revealed an exclusive fashion-and-beauty collaboration alongside the opening of a new San Antonio location offering products and salon services. Together, these partnerships and footprint expansion moves highlight Ulta Beauty’s push to broaden its assortment, reach younger shoppers, and deepen its presence across...

In recent months, Liquidia reported its third consecutive profitable quarter, with stronger sales and earnings supported by real-world demand for its FDA-approved pulmonary hypertension therapy YUTREPIA. At the same time, an expanded financing agreement with HealthCare Royalty for up to US$100,000,000 has increased the capital available to support YUTREPIA’s commercialization and Liquidia’s broader pipeline. Next, we’ll examine how sustained profitability from YUTREPIA, backed by the...

What Snap’s latest earnings mean for shareholders Snap (SNAP) just reported second quarter 2026 results, with sales of US$1.6b and a net loss of US$164m, triggering fresh attention on whether the stock’s recent rally has support. See our latest analysis for Snap. Snap’s recent earnings update has coincided with a sharp shift in sentiment, with the 7 day share price return of 13.65% and 30 day share price return of 15.12% contrasting with a year to date share price decline of 34.44% and a 5...

Futu Holdings stock has fallen sharply over the past year, yet the intrinsic value estimate from the Excess Returns model and the market multiples both point to the shares trading at a discount to fair value. Over the last 3 years, Futu Holdings has returned 130.1%, which sets a strong recent track record compared with its weaker shorter-term share price performance. Expectations for continued growth in its online brokerage and wealth management operations can support the current valuation...